Patents
Sitemap › G01 - Measuring; Testing › G01N - Investigating or analysing materials by determining their chemical or physical properties › G01N 33 - Investigating or analysing materials by specific methods not covered by groups
Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632)
09/2003
09/16/2003US6622052 Flexible protocol generator
09/16/2003US6621075 Device for delivery of multiple liquid sample streams to a mass spectrometer
09/16/2003US6620915 Monoclonal antibodies specific for integrin α-d subunit
09/16/2003US6620800 Assess oxidative stress in vivo includes the steps of measuring an amount of neuroprostanes in a biological sample before the ex vivo development of neuroprostanes in a sample, comparing the measured amount of neuroprostanes with a control
09/16/2003US6620790 Stimulate hair growth
09/16/2003US6620789 Compounds are provided that inhibit the interaction of an IGF with any one of its binding proteins and not to a human IGF receptor. These IGF agonist compounds, which include peptides, are useful to increase serum and tissue levels of active IGFs
09/16/2003US6620787 Utilization of mass spectroscopy to elucidate particular biopolymer markers indicative of disease state; biopolymer sequences having a unique relationship to at least one particular disease state
09/16/2003US6620786 Utilization of mass spectroscopy to elucidate particular biopolymer markers indicative of disease state; biopolymer sequences having a unique relationship to at least one particular disease state
09/16/2003US6620784 Uses of VEGF-E
09/16/2003US6620629 Method for detecting prions
09/16/2003US6620628 Analytical elements having a surface charge
09/16/2003US6620627 Kit, for isolating tumor cells, comprising a reagent to inactivate endogenous aggregating factors, antibody coupled to base coating material
09/16/2003US6620626 Antigen detection device and method
09/16/2003US6620621 Analyzing cells using infrared analysis and creating records used for evaluation of dysplasia; medical diagnosis
09/16/2003US6620607 Polypeptides having amino acid sequences coded by genes within the human genome, used as proteolytic enzymes for therapy and medical diagnosis
09/16/2003US6620591 System for cell-based screening
09/16/2003US6620590 Diagnosis of pre-eclampsia
09/16/2003US6620589 NMR-solve method for rapid identification of Bi-ligand drug candidates
09/16/2003US6620588 High throughput assay for drug screening comprising incubating nucleic acids, topoisomerase and enzyme inhibitors, the anlayzing genetic ligation
09/16/2003US6620583 Diagnostic screens for type 1 diabetes (IDDM)
09/16/2003US6620384 Double handhold to prevent urine-test cheating
09/16/2003US6620315 System for optimized control of multiple oxidizer feedstreams
09/16/2003US6620310 Rapid, accurate, simple prothrombin time determinations using small sample volumes
09/16/2003US6620112 Disposable lancet combined with a reagent carrying strip and a system for extracting and analyzing blood in the body utilizing such a disposable lancet
09/16/2003US6620109 Method and system of diagnosing intrapulmonary infection using an electronic nose
09/16/2003US6620107 Detection of conditions by analysis of gases or vapours
09/16/2003US6620106 Indirect calorimetry system
09/16/2003US6619107 Simple method of measuring nitrogen oxide in running vehicles
09/16/2003US6619103 Sample flow path assembly for electronic gas leak detectors
09/16/2003US6618934 Method of manufacturing small volume in vitro analyte sensor
09/16/2003CA2285943C Probe for detection of the concentration of various elements in molten metal
09/16/2003CA2140252C A snow grooming device
09/16/2003CA2131719C Nucleic acid sequences coding for or complementary to nucleic acid sequences coding for interleukin 9 receptor
09/16/2003CA2099374C Diagnostic method for detecting the rupture of fetal membranes and test kit employing the method
09/16/2003CA2090860C Synthesis of equimolar multiple oligomer mixtures, especially of oligopeptide mixtures
09/15/2003CA2422224A1 System, method, and product for scanning of biological materials
09/14/2003CA2421467A1 Test strip qualification system
09/14/2003CA2421355A1 Test strip qualification system
09/13/2003CA2376747A1 Apparatus for quantitative in vivo optical measurement of a mammalian analyte concentration and use thereof
09/12/2003WO2003075307A1 Methods, devices, and systems using acoustic ejection for depositing fluid droplets on a sample surface for analysis
09/12/2003WO2003075306A1 Method for protein identification using mass spectrometry data
09/12/2003WO2003075294A1 On-line detection and measurement system for gases in oil-filled electrical equipment
09/12/2003WO2003075129A2 Methods, systems, and software for identifying functional bio-molecules
09/12/2003WO2003075016A1 Scd fingerprints
09/12/2003WO2003075015A2 Methods of screening apoptosis modulating compounds, compounds identified by said methods and use of said compounds as therapeutic agents
09/12/2003WO2003075014A2 Protein-protein interactions in human tumours involving bcmp-7 and bcmp-11
09/12/2003WO2003075013A1 Method of measuring the activity of dna-binding protein
09/12/2003WO2003075012A1 Matrix for coupling of a biological molecule, method for producing and use of said matrix
09/12/2003WO2003075011A1 Instruments for detecting low-molecular weight substance
09/12/2003WO2003075010A2 Non-peptide immunologic tracer precursors comprising a tyrosyl-(x)n or lysine-(x)n tyrosine motif
09/12/2003WO2003075009A1 Use of nucloeoside derivatives comprising a citrate group for producing antibodies having affinity for triphosphorylated nucleosides and uses thereof
09/12/2003WO2003075008A1 Absorbing organic reagent into diagnostic test devices by formation of amine salt complexes
09/12/2003WO2003075007A2 Methods for absolute cell counting
09/12/2003WO2003075006A1 Determination of compatibility of a set of chemical modifications with an amino-acid chain
09/12/2003WO2003075005A1 Fungal antigens and eosinophil activity
09/12/2003WO2003075003A1 Therapeutic properties of oils
09/12/2003WO2003075001A1 Gas chromatograph and expired air component analyzer
09/12/2003WO2003075000A1 Method for the detection of proteins of animal origin in complex mixtures
09/12/2003WO2003074999A1 Biosensor
09/12/2003WO2003074997A2 Detection of carbon monoxide in hydrogen-based gas streams
09/12/2003WO2003074996A2 Method and device for analyzing molten masses
09/12/2003WO2003074992A2 Phosphorylated proteins and uses related thereto
09/12/2003WO2003074991A2 Method and sampling device for detection of low levels of a property/quality trait present in an inhomogeneously distributed sample substrate
09/12/2003WO2003074990A2 Artificial receptors, building blocks, and methods
09/12/2003WO2003074739A2 Automated allele determination using fluorometric genotyping
09/12/2003WO2003074736A1 Diagnostics and remedies for malignant brain tumor
09/12/2003WO2003074735A1 Diagnostic method for glaucoma
09/12/2003WO2003074730A1 Method and device for determination of tissue specificity of free floating dna in bodily fluids
09/12/2003WO2003074727A1 Rapid identification of yeasts
09/12/2003WO2003074725A2 MBCATs AS MODIFIERS OF THE BETA-CATENIN PATHWAY AND METHODS OF USE
09/12/2003WO2003074722A2 Microarrays of cellulose binding chimeric proteins and methods of use thereof
09/12/2003WO2003074704A1 Proteins capable of binding to female sex hormones and process for producing the same
09/12/2003WO2003074695A1 Sumo inhibitors
09/12/2003WO2003074694A1 Adipocyte differentiation-associated genes and proteins
09/12/2003WO2003074684A1 Cells capable of differentiating into myocardium-like cells
09/12/2003WO2003074683A1 Cmos process-compatible high dielectric constant surface coating for the detection and stimulation of biological tissue
09/12/2003WO2003074674A2 MSRAs AS MODIFIERS OF THE p53 PATHWAY AND METHODS OF USE
09/12/2003WO2003074671A2 Mbcats as modifiers of the beta-catenin pathway and methods of use
09/12/2003WO2003074662A2 SCDs AS MODIFIERS OF THE p53 PATHWAY AND METHODS OF USE
09/12/2003WO2003074659A2 Magnetic immobilization of cells
09/12/2003WO2003074652A2 Methods for identifying agents that modulate mast cell degranulation
09/12/2003WO2003074651A1 Reaction cell and method of using the cell
09/12/2003WO2003074630A1 Fine particle containing rare earth element and fluorescent probe using the same
09/12/2003WO2003074549A2 Assay for anti-ingap antibodies
09/12/2003WO2003074548A2 Phage ligand sensor devices and uses thereof
09/12/2003WO2003074263A1 Method and device for evaluating compression molding characteristics of powder
09/12/2003WO2003074154A1 Apparatus and method for separating and collecting particles
09/12/2003WO2003074147A1 Method for monitoring the quality of a herbal medicine
09/12/2003WO2003074128A2 Atomic structure of the hemalbumin complex and its use in designing therapeutic compounds
09/12/2003WO2003074080A1 Treatment of central nervous system damage
09/12/2003WO2003074073A2 Genes involved in regulating angiogenesis, pharmaceutical preparations containing same and applications thereof
09/12/2003WO2003074069A2 Diagnostics and therapeutics for diseases associated with the n-formyl peptide receptor 1 (fpr 1)
09/12/2003WO2003074059A2 Materials and methods relating to the treatment of lymphoma
09/12/2003WO2003074007A2 Modulators of leukocyte activation, compositions, and methods of use
09/12/2003WO2003073996A2 Human schwannoma cell line
09/12/2003WO2003073992A2 Method and composition for detecting early hiv antibody
09/12/2003WO2003073991A2 Methods to increase or decrease bone density
09/12/2003WO2003073990A2 Treatment for asthma or allergies
09/12/2003WO2003073983A2 Methods and compositions in treating pain using diacylglycerol kinase epsilon
09/12/2003WO2003073980A2 Recombinant protein c variants
1 ... 2509 2510 2511 2512 2513 2514 2515 2516 2517 2518 2519 2520 2521 2522 2523 2524 2525 2526 2527 2528 2529 ... 3937